<DOC>
	<DOCNO>NCT02330484</DOCNO>
	<brief_summary>Based patient ' HbA1c improvement , study aim establish incentive strategy family physicians patient respectively evaluate affect adherence medication among patient type2 diabetes .</brief_summary>
	<brief_title>Affect Incentive Strategy Adherence Medication Among Patients With Type 2 Diabetes</brief_title>
	<detailed_description>First step : In study , investigator conduct open-label control randomized cluster trial enroll 400 eligible voluntary patient type 2 diabetes community . 16 physician involve study patient management . Each physician care least 20 patient random unit divide 4 group baseline assessment include demographic characteristic , diabetes diagnosis treatment , complication , biochemical index self-management . The involved patient physician receive related training . The patient sign inform consent form . Second step : This study aim give incentive physician patient physician patient base HbA1c improvement . All patient sign inform consent form . Regarding control group , health course community management give usual . investigator evaluate condition patient ' medication adherence give incentive . Third step : MEMS use intervention monitoring patient ' medication adherence . As monitoring instrument , MEMS ( Aardex , Zurich , Switzerland ) plastic container spring-loaded device cap . Each time bottle open least 3 second , time date opening record save . Based research data HbA1c improvement , study analyze factor affect patient ' adherence medication . Meanwhile , investigator collect patient ' information blood pressure , biochemical index , complication relate diabetes , life quality , self-management , life style , health behavior , medication , health expenditure evaluate affect incentive strategy adherence medication among patient type 2 diabetes . Endpoint study : The study end 12 month , endpoint measurement indicator list : 1 . The study end 12 month 2 . Patient 's drop study 3 . Stopping take oral hypoglycemic drug 4 . The diabetic condition worsen , need surgery hospitalization treatment 5 . Frequency severe hypoglycemia complication continue study 6 . Death patient</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Confirmed type 2 diabetes patient ( ICD9 ) accord medical record patient 's disease history 2 . 40 74 year old 3 . Diagnosis type 2 diabetes 6 month 4 . Take least one kind oral hypoglycemic medication ( include insulin injection ) 5 . Got treatment community hospital follow 12 month 6 . Have medical insurance 7 . Stable condition adverse indication 8 . Participate study voluntarily sign inform consent 1 . Terminal illness 2 . Serious hear visual disorder 3 . Intend receive selective surgery , get pregnancy breast feed three month 4 . Demnentia communication disorder 5 . Mental disorder 6 . The paralyzed handicap 7 . Expected survival time less oneyear</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Community managementï¼Œ incentive , Medication Adherence</keyword>
</DOC>